Google says AH-MUH-KRAN is 🇺🇸 & OH-MU-KRON is 🇬🇧
Oversimplified..
In ancient Greek, there were 2 letters pronounced similarly:
Ω made a long Oooo - it was called big O or O Mega
Ο made a short Oo - it was called little O or O Micron
Thus, OH-MI-KRON is probably more accurate 2/
To understand Omicron, we need to understand pandemic surveillance:
A sick person 🤒 gets COVID tested.
The (+) results get sequenced (depending on where in the 🌎 ) & published to @GISAID (or other platform).
Sequences are used by researchers globally, such as @nextstrain. 3/
Using @nextstrain to analyze those surveillance sequences we can watch the evolution of Omicron unfold:
Note the appearance of variants, particularly Delta in Summer 2021.
Omicron appears in October/November 2021.
On November 26, the WHO declared it a variant of concern. 4/
Omicron has ~50 mutations (compared to the original strain) but >30 of them are in one gene: the Spike Protein
This is worrisome because the Spike (S) protein binds to ACE2. It's also what our immune system "sees" & makes Ab against
One mutation is actually useful:
The TaqPath test amplifies the S gene using PCR.
In omicron the S gene won't amplify because of deletion of 2 residues (H69-, V70-). We call the failure to amplify S Gene Target Failure (SGTF).
👉🏻You may see "SGTF" as a surrogate for Omicron 7/
Because sequences are available, the effect of the mutations can be studied in vitro & in silico
Redd et al found that despite the spike protein mutations virtually all T-cell epitopes were preserved, suggesting the virus hasn't evaded T cell immunity biorxiv.org/content/10.110… 8/
Another lab (Garcia-Beltran et al) found that pseudovirus particles made with the Omicron mutant spike protein were significantly more able to infect ACE2 expressing 293T cells
There’s a new SARS-CoV-2 variant of concern: Omicron (aka B.1.1.529) #OmicronVariant
What is this Omicron COVID variant & is the panic of it justified? (spoiler alert: no)
A short #OmicronExplainer 🧵 about what we actually know, what we suspect, & what’s still unknown. 1/
4 reasons Omicron is worrisome:
1️⃣ it is spreading rapidly in South Africa (known)
2️⃣ it is highly mutated (known)
3️⃣some mutations likely increase transmissibility (suspected)
4️⃣others *may* allow it to evade existing immunity or vaccines (unknown)
We’ll talk about all 4...
2/
First some nomenclature:
B.1.1.529 (its Pango lineage) is the same as “Omicron" (WHO declared it a variant of concern & assigned a Greek letter) #OmicronVariant
It’s also known as K21 (Nextstrain clade)
It’s erroneously been called the #NuVariant ... yeah that’s not a thing 3/
Hieronymus Karl Friedrich Freiherr von Münchhausen, a German Baron, was legendary for telling stories of his adventures in the Russian Cavalry during the Russo-Turkish War.
(even the dogs look entertained!)
Notably he was *NOT* regarded as a liar but as a great story-teller! 2/
A German writer & con-artist, Rudolf Erich Raspe, created a fictional character Baron Munchausen loosely based on Baron Münchhausen (note the spelling: u not ü)
Munchausen had incredible adventures such as riding a cannonball, fighting a 40 foot crocodile, & going to the Moon 3/
💊Exciting news today about another oral therapy for early COVID: reduced hospitalization & mortality.
Here’s a Deep dive 🧵 on the new PF-07321332 protease inhibitor (“Paxlovid”) & the very impressive results announced from the EPIC-HR trial.
TL/DR: this is a big deal. 1/
What the heck is PF-07321332?
All coronaviruses produce a polypeptide that must be cleaved by a protease into 11 proteins. Without this protease the virus can’t co-opt cellar machinery & reproduce.
PF-07321332 Inhibits the viral main protease (Mpro). 2/
Specifically PF-07321332 binds to the catalytic site of Mpro.
Mpro is a great target because there are unique features of Mpro not found in *any* human enzymes & because spike protein mutations wouldn’t confer resistance.
🚨Results of the #ITECH RCT in Malaysia 🇲🇾 are in & it’s yet another NEGATIVE result for ivermectin:
-n=500 high risk outpatients w/COVID randomized to 0.4 mg/kg IVM x5 days vs SOC
-no difference in rate of progression or time to recovery
-3x more adverse events w/ ivermectin 1/
We don’t have the full results yet but based on the 🇲🇾 Ministry of Health data this was a NEGATIVE trial.
- IVM recipients did numerically worse: 21.2% progressed to severe disease vs 17.9% receiving SOC (OR 1.29 CI 0.8-2.0)
- time to progression was similar: 2.9 vs 3 days 3/
If you think no one is getting rich off of ivermectin, definitely don't watch this video from FLCCC founder Dr. Fred Wagshul.
For just $276 (cash only, no insurance), this quack will prescribe ivermectin "no questions asked." Don't worry he's got "plenty of product."
Yikes! 1/
His website makes it really clear.
You just fill out this form (including your SSN) and send it to a not at all sketchy gmail address.
Then you pay $211 for a 3 minute phone call and get your prescription. Plus $75 for a followup. Then $75 recurring every 6 months. 2/
There are quite a few 🚩 on this website.
Aside from referring to $276 telehealth prescriptions for ivermectin as "preventive maintenance" this pulmonologist is also apparently an expert in... interstitial cystitis?
So pulm and urology under one roof. Not at all sketchy. 3/
Interesting results from the #TOGETHER RCT of #fluvoxamine vs placebo in n=1497 high risk outpatients in 🇧🇷 with #COVID:
-people who received fluvoxamine were less likely to require extended ED visit or hospitalization (11% vs 16%, RR 0.68 CI 0.52-0.88) thelancet.com/journals/langl… 1/
TOGETHER was a large, multi-arm adaptive platform DB-RCT done in 🇧🇷 Brazil from June 2020 to Jan 2021.
Patients were identified after testing positive, stratified by age (>50 or <50 yo) & randomized to fluvoxamine 100 mg BID x 10 days vs placebo.
2/
It builds upon 2 studies:
-an observational study in 🇫🇷 that found better outcomes among inpts already taking SSRIs nature.com/articles/s4138…
-a small n=152 RCT done in 🇺🇸 showing a decrease in clinical deterioration among outpts randomized to Fluvoxamine jamanetwork.com/journals/jama/… 3/